Table 1 Malarial invention patents filed by domestic and foreign entities and its grant ratiosa
From: Domestic trends in malaria research and development in China and its global influence
Fields | 1985–1994 | 1995–2004 | 2005–2014 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Domestic | Foreign | Domestic | Foreign | Domestic | Foreign | ||||||||||||
| Â | All | Public | Private | All | Public | Private | All | Public | Private | All | Public | Private | All | Public | Private | All | Public | Private |
Vaccines | 0 (0) | 0 (0) | 0 (0) | 12 (8.3%) | 1 (0) | 11 (9.1%) | 4 (75.0%) | 3 (66.6%) | 1 (100%) | 38 (42.1%) | 13 (30.8%) | 25 (48.0%) | 21 (57.1%) | 15 (66.7%) | 6 (33.3%) | 111 (12.6%) | 29 (13.8%) | 82 (12.2%) |
Drugs | 3 (33.3%) | 1 (100%) | 2 (0) | 3 (33.3%) | 0 (0) | 3 (33.3%) | 11 (81.8%) | 3 (100%) | 8 (75.0%) | 21 (42.9%) | 5 (60.0%) | 16 (37.5%) | 34 (38.2%) | 9 (55.6%) | 25 (32.0%) | 80 (11.3%) | 17 (11.8%) | 63 (11.1%) |
Diagnostics | 0 (0) | 0 (0) | 0 (0) | 3 (33.3%) | 1 (100%) | 2 (0) | 1 (100%) | 0 (0) | 1 (100%) | 7 (57.1%) | 2 (100%) | 5 (40.0%) | 3 (33.3%) | 2 (0) | 1 (100%) | 40 (15.0%) | 9 (22.2%) | 31 (6.3%) |
Total | 3 (33.3%) | 1 (100%) | 2 (0) | 18 (16.7%) | 2 (50%) | 16 (12.5%) | 16 (81.3%) | 6 (83.3%) | 10 (80.0%) | 66 (43.9%) | 20 (45.0%) | 46 (43.5%) | 58 (43.5%) | 26 (57.7%) | 32 (60.0%) | 231 (12.6%) | 55 (14.5%) | 176 (10.8%) |